Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/14/2025 | $181.00 | Perform → Outperform | Oppenheimer |
| 10/13/2025 | $150.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 10/3/2025 | $150.00 | Outperform | BMO Capital Markets |
| 9/18/2025 | $162.00 | Sell → Neutral | Goldman |
| 5/15/2025 | Outperform → Perform | Oppenheimer | |
| 1/21/2025 | $186.00 | Perform → Outperform | Oppenheimer |
| 1/6/2025 | $139.00 | Neutral → Sell | Goldman |
| 9/12/2024 | $156.00 | Equal Weight | Wells Fargo |
4 - Hamilton Lane INC (0001433642) (Issuer)
- KAIO has been leading the tokenization of major institutional funds, expanding crypto-native access to regulated money markets and alternative investment strategies - The tokenization of Hamilton Lane SCOPE Fund on Sei's DeFi optimized design is expected to enhance accessibility for the fund's investors ABU DHABI, UAE, Oct. 15, 2025 /PRNewswire/ -- KAIO, the leading fully onchain infrastructure for regulated real-world assets (RWAs), today announced the expansion of its tokenized fund offerings on the Sei Network by bringing access to Hamilton Lane's (NASDAQ:HLNE) Senior Credit Opportunities Fund ("SCOPE") onchain, via HL SCOPE Access Fund1, for institutional and accredited inv
CONSHOHOCKEN, Pa., Oct. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 10:00 a.m. ET on November 4 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at lea
Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets Novata, a leading sustainability data management platform for private markets, today announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move expands Novata's global reach and unites two complementary companies to meet the growing demand from investors and corporates for trusted, efficient, and scalable sustainability data solutions. Together, Novata and Atlas Metrics now supports more than 400 clients and 13K+ companies worldwide, equipping investors, banks, and corporates with the tools th
3 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00
Keefe Bruyette upgraded Hamilton Lane from Mkt Perform to Outperform and set a new price target of $150.00
BMO Capital Markets initiated coverage of Hamilton Lane with a rating of Outperform and set a new price target of $150.00
8-K - Hamilton Lane INC (0001433642) (Filer)
8-K - Hamilton Lane INC (0001433642) (Filer)
8-K - Hamilton Lane INC (0001433642) (Filer)
-- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co
Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I
Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo
- KAIO has been leading the tokenization of major institutional funds, expanding crypto-native access to regulated money markets and alternative investment strategies - The tokenization of Hamilton Lane SCOPE Fund on Sei's DeFi optimized design is expected to enhance accessibility for the fund's investors ABU DHABI, UAE, Oct. 15, 2025 /PRNewswire/ -- KAIO, the leading fully onchain infrastructure for regulated real-world assets (RWAs), today announced the expansion of its tokenized fund offerings on the Sei Network by bringing access to Hamilton Lane's (NASDAQ:HLNE) Senior Credit Opportunities Fund ("SCOPE") onchain, via HL SCOPE Access Fund1, for institutional and accredited inv
CONSHOHOCKEN, Pa., Oct. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 10:00 a.m. ET on November 4 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at lea
Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets Novata, a leading sustainability data management platform for private markets, today announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move expands Novata's global reach and unites two complementary companies to meet the growing demand from investors and corporates for trusted, efficient, and scalable sustainability data solutions. Together, Novata and Atlas Metrics now supports more than 400 clients and 13K+ companies worldwide, equipping investors, banks, and corporates with the tools th
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)